Latest Post

April 09, 2021

Vial Compatibility with Closed System Transfer Devices

Unanticipated incompatibilities between the drug product and a closed system transfer device (CSTD) delay therapeutic delivery to the patient. Considering the CSTD with the drug product and even co-packaging the drug product with an optimal FDA-approved CSTD will positively impact drug product therapeutic performance and ultimately patient care.
Aaron Chapman

Aaron Chapman PhD

Program Manager, Commercial Technology Development

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

  • Previous Posts
    NovaGuard SA Pro Safety System

    March 22, 2021

    Prevention of Needlestick Injuries with Safety Systems

    Katalin Halbrucker

    Katalin Halbrucker

    Technical Account Specialist, TCS, EU

    Prefilled Glass Syringes with NovaPure plungers

    January 25, 2021

    Benefits of Prefilled Syringes

    Mary Tan

    Mary Tan

    Specialist, Scientific Affairs, Singapore

    Cell and Gene Therapy

    September 28, 2020

    Overcoming the Challenge of Maintaining Sterility at Low Temperature Storage

    Abigail Hisler

    Abbey Hisler

    Director, Strategic Marketing, Biologics

    COVID-19 Whitepaper

    September 02, 2020

    SARS-CoV-2 Vaccines – Alternative Vial Components

    Whitney Winters

    Whitney Winters

    Sr. Director, Strategic Marketing, Containment Systems

    Bettine Boltres presents at PDA Webinar

    August 24, 2020

    How to Include Elastomers in the Nitrosamine Risk Assessment

    Bettine Boltres

    Dr. Bettine Boltres

    Principal Scientific Affairs, Packaging & Delivery Systems

    Load more